535 related articles for article (PubMed ID: 17437408)
1. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
Hoffmann K; Löscher W
Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
[TBL] [Abstract][Full Text] [Related]
2. Expression of the multidrug transporter MRP2 in the blood-brain barrier after pilocarpine-induced seizures in rats.
Hoffmann K; Gastens AM; Volk HA; Löscher W
Epilepsy Res; 2006 Apr; 69(1):1-14. PubMed ID: 16504477
[TBL] [Abstract][Full Text] [Related]
3. Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.
Potschka H; Fedrowitz M; Löscher W
Epilepsia; 2003 Dec; 44(12):1479-86. PubMed ID: 14636316
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity.
Potschka H; Fedrowitz M; Löscher W
J Pharmacol Exp Ther; 2003 Jul; 306(1):124-31. PubMed ID: 12663688
[TBL] [Abstract][Full Text] [Related]
5. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
[TBL] [Abstract][Full Text] [Related]
6. Increasing nerve agent treatment efficacy by P-glycoprotein inhibition.
Joosen MJA; Vester SM; Hamelink J; Klaassen SD; van den Berg RM
Chem Biol Interact; 2016 Nov; 259(Pt B):115-121. PubMed ID: 27287416
[TBL] [Abstract][Full Text] [Related]
7. Characterization of transport protein expression in multidrug resistance-associated protein (Mrp) 2-deficient rats.
Johnson BM; Zhang P; Schuetz JD; Brouwer KL
Drug Metab Dispos; 2006 Apr; 34(4):556-62. PubMed ID: 16204465
[TBL] [Abstract][Full Text] [Related]
8. Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.
Volk HA; Burkhardt K; Potschka H; Chen J; Becker A; Löscher W
Neuroscience; 2004; 123(3):751-9. PubMed ID: 14706787
[TBL] [Abstract][Full Text] [Related]
9. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug transporter P-glycoprotein in brain capillary endothelial cells and brain parenchyma of amygdala-kindled rats.
Seegers U; Potschka H; Löscher W
Epilepsia; 2002 Jul; 43(7):675-84. PubMed ID: 12102668
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid is not a substrate for P-glycoprotein or multidrug resistance proteins 1 and 2 in a number of in vitro and in vivo transport assays.
Baltes S; Fedrowitz M; Tortós CL; Potschka H; Löscher W
J Pharmacol Exp Ther; 2007 Jan; 320(1):331-43. PubMed ID: 17043155
[TBL] [Abstract][Full Text] [Related]
12. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
13. Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.
Lazarowski A; Ramos AJ; García-Rivello H; Brusco A; Girardi E
Cell Mol Neurobiol; 2004 Feb; 24(1):77-85. PubMed ID: 15049512
[TBL] [Abstract][Full Text] [Related]
14. Minor compensatory changes in SAGE Mdr1a (P-gp), Bcrp, and Mrp2 knockout rats do not detract from their utility in the study of transporter-mediated pharmacokinetics.
Zamek-Gliszczynski MJ; Goldstein KM; Paulman A; Baker TK; Ryan TP
Drug Metab Dispos; 2013 Jun; 41(6):1174-8. PubMed ID: 23569176
[TBL] [Abstract][Full Text] [Related]
15. Involvement of multidrug resistance associated protein 1 (Mrp1) in the efflux transport of 17beta estradiol-D-17beta-glucuronide (E217betaG) across the blood-brain barrier.
Sugiyama D; Kusuhara H; Lee YJ; Sugiyama Y
Pharm Res; 2003 Sep; 20(9):1394-400. PubMed ID: 14567633
[TBL] [Abstract][Full Text] [Related]
16. Suppression of efflux transporters in the intestines of endotoxin-treated rats.
Tomita M; Takizawa Y; Kanbayashi A; Murata H; Tanaka A; Nakaike M; Hatanaka M; Kai T; Hayashi M
Int J Pharm; 2012 May; 428(1-2):33-8. PubMed ID: 22387888
[TBL] [Abstract][Full Text] [Related]
17. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
18. Glutamate is critically involved in seizure-induced overexpression of P-glycoprotein in the brain.
Bankstahl JP; Hoffmann K; Bethmann K; Löscher W
Neuropharmacology; 2008 May; 54(6):1006-16. PubMed ID: 18394657
[TBL] [Abstract][Full Text] [Related]
19. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
20. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
